Antibody-dependent enhancement of virus infection and disease

Viral Immunology

Volumn 16, Issue 1, 2003, Pages 69-86

  Tirado, Sol M Cancel ^a   Yoon, Kyoung Jin ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT RECEPTOR; EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS PROTEIN; VIRUS VACCINE;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY SPECIFICITY; ANTIGENIC VARIATION; ARTERIVIRUS; ARTICLE; CORONAVIRUS; DENGUE VIRUS; GRANULOCYTE; HUMAN; LENTIVIRINAE; MACROPHAGE; MONOCYTE; NONHUMAN; PARVOVIRUS; PERSISTENT VIRUS INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ARTERIVIRUS; CORONAVIRUS; DENGUE VIRUS; DNA VIRUSES; LENTIVIRUS; PARVOVIRUS; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RNA VIRUSES;

EID: 0037257790     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403763635465     Document Type: Article

References (143)

1. Ahl, R., M. Pensaert, I.B. Robertson, et al. 1992. Porcine reproductive and respiratory syndrome (PRRS or blue-eared pig disease). Vet Rec 130:87-89.
2. Allende, R., W.W. Laegreid, G.F. Kutish, et al. 2000. Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J Virol 74:10834-10837.
3. Anderson, C.L., and R.J. Looneyl. 1986. Human leukocyte IgG Fc receptors. Immunol Today 7:264-266.
4. Baldinotti, F., D. Matteucci, P. Mazzetti, et al. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J Virol 68:4572-4579.
5. Baxt, B., and P.W. Mason. 1995. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 207:503-509.
6. Bendinelli, M., M. Pistello, S. Lombardi, et al. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 8:87-112.
7. Blancou, J., B. Andral, and L. Andral. 1980. A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus. J Gen Virol 50:433-435.
8. Brandt, W.E. 1988. From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. J Infect Dis 157:1105-1111.
9. Brandt, W.E., J.M. McCown, M.K. Gentry, et al. 1982. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immunol 36:1036-1041.
10. Burke, D.S. 1992. Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk? Perspect Biol Med 35:511-530.
11. Burke, D.S., A. Nisalak, D.E. Johnson, et al. 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38:172-180.
12. Burstin, S.J., M.W. Brandriss, and J.J. Schlesinger. 1983. Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth. J Immunol 130:2915-2919.
13. Cafruny, W.A., and P.G.W. Plagemann. 1981. Immune enhancement of macrophage infection with lactate dehydrogenase-elevating virus. Fed Proc 40:1120.
14. Cafruny, W.A., and P.G.W. Plagemann. 1982. Immune response to lactate dehydrogenase-elevating virus: Serologically specific rabbit neutralizing antibody to the virus. Infect Immun 37:1007-1012.
15. Cardosa, M.J., J.S. Porterfield, and S. Gordon. 1983. Complement receptor mediates enhanced flavivirus replication in macrophages. J Exp Med 158:258-263.
16. Chanas, A.C., E.A. Gould, J.C. Clegg, et al. 1982. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol 58:37-46.
17. Chanock, R.M., A.Z. Kapikian, J. Mills, et al. 1970. Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health 21:347-355.
18. Chanock, R.M., R.H. Rarrott, A.Z. Kapikian, et al. 1968. Possible role of immunological factors in pathogenesis of RS virus in lower respiratory tract disease. Perspect Virol 6:125-135.
19. Chen, R., W. Yeh, M. Yang, et al. 2001. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol 30:1-7.
20. Chin, J., R.L. Magoffin, L.A. Shearer, et al. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89:449-463.
21. Choi, C., W.T. Christianson, J.E. Collins, et al. 1992. Antibody-dependent enhancement of SIRS virus replication. Am Assoc Swine Pract Newslett 4:30.
22. Christianson, W.T., C.S. Choi, J.E. Collins, et al. 1993. Pathogenesis of porcine reproductive and respiratory syndrome virus infection in mid-gestation sows and fetuses. Can J Vet Res 57:262-268.
23. Corapi, W.V., C.W. Olsen, and F.W. Scott. 1992. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 66:6695-6705.
24. Daughaday, C.C., W.E. Brandt, J.M. McCown, et al. 1981. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: Trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immunol 32:469-473.
25. Debets, J.M., J.G. Van de Winkel, J.L. Ceuppens, et al. 1990. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase. J Immunol 144:1304-1310.
26. Diamond, B., B.R. Bloom, and M.D. Scharff. 1978. The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol 121:1329-1333.
27. Dworak, L.J., J.B. Wolfinbarger, and M.E. Bloom. 1997. Aleutian mink disease parvovirus infection of K562 cells is antibody-dependent and is mediated via an Fc(gamma)RII receptor. Arch Virol 142:363-373.
28. Fagbami, A.H., S.B. Halstead, N.J. Marchette, et al. 1987. Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids. Cytobios 49:49-55.
29. Ferguson, N., R. Anderson, and S. Gupta. 1999. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci USA 96:790-794.
30. Fulginiti, V.A., J.J. Eller, O.F. Sieber, et al. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435-448.
31. Gimenez, H.B., H.M. Keir, and P. Cash. 1989. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J Gen Virol 70:89-96.
32. Gollins, S.W., and J.S. Porterfield. 1984. Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. J Gen Virol 65:1261-1272.
33. Gollins, S.W., and J.S. Porterfield. 1985. Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. J Gen Virol 66:1969-1982.
34. Gollins, S.W., and J.S. Porterfield. 1986. A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321:244-246.
35. Gras, G.S., and D. Dormont. 1991. Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line. J Virol 65:541-545.
36. Halstead, S.B. 1970. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42:350-362.
37. Halstead, S.B. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140:527-533.
38. Halstead, S.B. 1980. Dengue haemorrhagic fever - a public health problem and a field for research. Bull WHO 58:1-21.
39. Halstead, S.B. 1980. Immunological parameterof togavirus disease syndromes. In: The Togaviruses: Biology, Structure, Replication. Ed. Schlesinger RW, Academic Press, New York, 107-173.
40. Halstead, S.B. 1981. The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am J Epidemiol 114:632-648.
41. Halstead, S.B. 1982. Immune enhancement of viral infection. Prog Allergy 31:301-364.
42. Halstead, S.B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
43. Halstead, S.B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 11:S830-839.
44. Halstead, S.B., S. Nimmannitya, and S.N. Cohen. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311-328.
45. Halstead, S.B., and E.J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739-741.
46. Halstead, S.B., and E.J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
47. Halstead, S.B., E.J. O'Rourke, and A.C. Allison. 1977. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 146:218-229.
48. Halstead, S.B., C.N. Venkateshan, M.K. Gentry, et al. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 132:1529-1532.
49. Haubrich, R.H., A. Takeda, W. Koff, et al. 1992. Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine. J Infect Dis 165:545-548.
50. Hawkes, R.A. 1964. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Aust J Exp Biol Med Sci 42:465-482.
51. Hawkes, R.A., and K.J. Lafferty. 1967. The enchancement of virus infectivity by antibody. Virology 33:250-261.
52. Henchal, E.A., J.M. McCown, D.S. Burke, et al. 1985. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg 34:162-169.
53. Hohdatsu, T., J. Tokunaga, and H. Koyama. 1994. The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages. Arch Virol 139:273-285.
54. Homsy, J., M. Meyer, M. Tateno, et al. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357-1360.
55. Hosie, M.J., R. Osborne, G. Reid, et al. 1992. Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol 35:191-197.
56. Huisman, W., J.A. Karlas, K.H. Siebelink, et al. 1998. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection. Vaccine 16:181-187.
57. Inada, T., K.T. Chong, and C.A. Mims. 1985. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol 66:871-878.
58. Inada, T., and Mims, C.A. 1985. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. J Gen Virol 66:1469-1477.
59. 2 and platelet-activating factor. Infect Immunol 68:1563-1568.
60. Issel, C.J. 1979. Equine infectious anemia: current knowledge. JAVMA 174:727-733.
61. Issel, C.J., D.W. Horohov, D.F. Lea, et al. 1992. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 66:3398-3408.
62. Jarrett, O., J.K. Yamamoto, and J.C. Neil. 1990. Feline immunodeficiency virus as a model for AIDS vaccination. AIDS 4(suppl 1):S163-165.
63. June, R.A., S.Z. Schade, M.J. Bankowski, et al. 1991. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS 5:269-274.
64. Kanno, H., J.B. Wolfinbarger, and M.E. Bloom. 1993. Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol 67:7017-7024.
65. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, et al. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421.
66. Kim, H.W., J.G. Canchola, C.D. Brandt, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422-434.
67. King, A.A., J.J. Sands, and J.S. Porterfield. 1984. Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1). J Gen Virol 65:1091-1093.
68. Kliks, S.C., A. Nisalak, W.E. Brandt, et al. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444-451.
69. Kontny, U., I. Kurane, and F.A. Ennis. 1988. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62:3928-3933.
70. Kurane, I., B.J. Mady, and F.A. Ennis. 1991. Antibody-dependent enhancement of dengue virus infection. Rev Med Virol 1:211-221.
71. Lager, K.M., and W.L. Mengeling. 1995. Pathogenesis of in utero infection in porcine fetuses with porcine reproductive and respiratory syndrome virus. Can J Vet Res 59:187-192.
72. Lidbury, B.A., and S. Mahalingam. 2000. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol 74:8376-8381.
73. Littaua, R., I. Kurane, and F.A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183-3186.
74. Mady, B.J., D.V. Erbe, I. Kurane, et al. 1991. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol 147:3139-3144.
75. Mady, B.J., I. Kurane, D.V. Erbe, et al. 1993. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection. J Gen Virol 74:839-844.
76. Mascola, J.R., B.J. Mathieson, P.M. Zack, et al. 1993. Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses 9:1175-1184.
77. Mason, P.W., B. Baxt, F. Brown, et al. 1993. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568-577.
78. Mason, P.W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci USA 91:1932-1936.
79. McGuire, T.C., D.S. Adams, G.C. Johnson, et al. 1986. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res 47:537-540.
80. Millican, D., and J.S. Porterfield. 1982. Relationship between glycoproteins of the viral envelope of bunyaviruses and antibody-dependent plaque enhancement. J Gen Virol 63:233-236.
81. Montefiori, D.C., M. Murphey-Corb, R.C. Desrosiers, et al. 1990. Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus. J Virol 64:5223-5225.
82. Morens, D.M., and S.B. Halstead. 1990. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 71:2909-2914.
83. Morens, D.M., C.N. Venkateshan, and S.B. Halstead. 1987. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. J Gen Virol 68:91-98.
84. Nauwynck, H.J., X. Duan, H.W. Favoreel, et al. 1999. Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor-mediated endocytosis. J Gen Virol 80:297-305.
85. Nelson, E.A., J. Christopher-Hennings, and D.A. Benfield. 1994. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J Vet Diagn Invest 6:410-415.
86. Ochiai, H., M. Kurokawa, K. Hayashi, et al. 1988. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol 62:20-26.
87. Ochiai, H., M. Kurokawa, S. Matsui, et al. 1992. Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody. J Med Virol 36:217-221.
88. Olsen, C., and F. Scott. 1993. Evaluation of antibody-dependent enhancement of feline infectious peritonitis virus infectivity using in situ hybridization. Microb Pathog 14:275-285.
89. Olsen, C.W., W.V. Corapi, C.K. Ngichabe, et al. 1992. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol 66:956-965.
90. Peiris, J.S., S. Gordon, J.C. Unkeless, et al. 1981. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature 289:189-191.
91. Perussia, B., E.T. Dayton, R. Lazarus, et al. 1983. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med 158:1092-1113.
92. Petersen, N.C., and J.F. Boyle. 1980. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 41:868-876.
93. Plagemann, P.G., and V. Moennig. 1992. Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res 41:99-192.
94. Porter, D.D., A.E. Larsen, and H.G. Porter. 1969. The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med 130:575-593.
95. Porter, D.D., A.E. Larsen, and H.G. Porter. 1972. The pathogenesis of Aleutian disease of mink. II. Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody. J Immunol 109:1-7.
96. Porter, D.D., A.E. Larsen, and H.G. Porter. 1980. Aleutian disease of mink. Adv Immunol 29:261-286.
97. Porterfield, J.S. 1981. Antibody-mediated enhancement of rabies virus. Nature 290:542.
98. Porterfield, J.S. 1986. Antibody-dependent enhancement of viral infectivity. Adv Virus Res 31:335-355.
99. Prabhakar, B.S., and N. Nathanson. 1981. Acute rabies death mediated by antibody. Nature 290:590-591.
100. Pyeon, D., F.J. Diaz, and G.A. Splitter. 2000. Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: Regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol 74:5740-5745.
101. Radkowski, M., T. Laskus, A. Goch, et al. 1993. Affinity of anti-GP41 antibody in patients infected with human immunodeficiency virus type 1. Eur J Clin Invest 23:455-458.
102. Ravetch, J.V., and J.P. Kinet. 1991. Fc receptors. Annu Rev Immunol 9:457-492.
103. Richardson, J., A. Moraillon, S. Baud, et al. 1997. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol 71:9640-9649.
104. Robinson, W.E., Jr., M.K. Gorny, J.Y. Xu, et al. 1991. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 65:4169-4176.
105. Robinson, W.E., Jr., T. Kawamura, M. K. Gorny, et al. 1990. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci USA 87:3185-3189.
106. Robinson, W.E., Jr., T. Kawamura, D. Lake, et al. 1990. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol 64:5301-5305.
107. Robinson, W.E., Jr., D.C. Montefiori, D.H. Gillespie, et al. 1989. Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. J Acquir Immune Defic Syndr 2:33-42.
108. Robinson, W.E., Jr., D.C. Montefiori, and W.M. Mitchell. 1987. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. Biochem Biophys Res Commun 149:693-699.
109. Robinson, W.E., Jr., D.C. Montefiori, and W.M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency virus type I infection. Lancet 1:790-794.
110. Robinson, W.E., Jr., D.C. Montefiori, and W.M. Mitchell. 1990. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175:600-604.
111. Roite, I., J. Brostoff, and D.K. Male. 1985. Cell-mediated immunity. In: Immunology, ed. Roite et al. Gower Medical Publishing Ltd, New York, 11.1-11.2.
112. Rossman, M.D., E. Chen, P. Chien, et al. 1989. Modulation of Fc gamma receptors on the human macrophage cell line U-937. Cell Immunol 120:174-187.
113. Sanchez, A., Z.Y. Yang, L. Xu, et al. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72:6442-6447.
114. Schlesinger, J.J., and M.W. Brandriss. 1991. Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. J Immunol 127:659-665.
115. Shahrabadi, M.S., H.J. Cho, and R.G. Marusyk. 1977. Characterization of the protein and nucleic acid of Aleutian disease virus. J Virol 23:353-362.
116. Sikes, R.K., W.F. Cleary, H. Koprowski, et al. 1971. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull WHO 45:1-11.
117. Stueckemann, J.A., Holth, M., Swart, W.J., et al. 1982. Replication of lactate dehydrogenase elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J Gen Virol 59:263-272.
118. Stueckemann, J.A., Ritzi, D.M., Holth, M., et al. 1982. Replication of lactate dehydrogenase elevating virus in macrophages. 1. Evidence for cytocidal replication. J Gen Virol 59:245-262.
119. Takada, A., S. Watanabe, K. Okazaki, et al. 2001. Infectivity-enhancing antibodies to Ebola virus glycoprotein. J Virol 75:2324-2330.
120. Takeda, A., R.W. Sweet, and F.A. Ennis. 1990. Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol 64:5605-5610.
121. Takeda, A., C.U. Tuazon, and F.A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
122. Tamura, M., R.G. Webster, and F.A. Ennis. 1991. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 182:211-219.
123. Tamura, M., R.G. Webster, and F.A. Ennis. 1994. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J Virol 68:3499-3504.
124. Theofilopoulos, A.N., W.E. Brandt, P.K. Russell, et al. 1976. Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol 117:953-961.
125. Therrien, D., Y. St-Pierre, and S. Dea. 2000. Preliminary characterization of protein binding factor for porcine reproductive and respiratory syndrome virus on the surface of permissive and non-permissive cells. Arch Virol 145:1099-1116.
126. Thomas, H. I., S. Wilson, C.M. O'Toole, et al. 1996. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol 103:185-191.
127. Unkeless, J.C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580-596.
128. Unkeless, J.C. 1989. Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest 83:355-361.
129. Van de Winkel, J.G., R. van Ommen, T.W. Huizinga, et al. 1989. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG. J Immunol 143:571-578.
130. Van den Broek, M.F., R. Sporri, C. Even, et al. 1997. Lactate dehydrogenase-elevating virus (LDV): lifelong co-existence of virus and LDV-specific immunity. J Immunol 159:1585-1588.
131. Van Reeth, K., and B. Adair. 1997. Macrophages and respiratory viruses. Pathol Biol (Paris) 45:184-192.
132. Vennema, H., R.J. de Groot, D.A. Harbour, et al. 1990. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 64:1407-1409.
133. Wang, S.Z., K.E. Rushlow, C.J. Issel, et al. 1994. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247-251.
134. Webster, R.G., and B.A. Askonas. 1980. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 10:396-401.
135. Weiss, R.C., and F.W. Scott. 1981. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 4:175-189.
136. Weiss, R.C., and F.W. Scott. 1981. Pathogenesis of feline infectious peritonitis: nature and development of viremia. Am J Vet Res 42:382-390.
137. Weiss, R.C., and F.W. Scott. 1981. Pathogenesis of feline infetious peritonitis: pathologic changes and immunofluorescence. Am J Vet Res 42:2036-2048.
138. Yang, K.D., W.T. Yeh, M.Y. Yang, et al. 2001. Antibody -dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol 63:150-157.
139. Yao, J.S., H. Kariwa, I. Takashima, et al. 1992. Antibody-dependent enhancement of hantavirus infection in macrophage cell lines. Arch Virol 122:107-118.
140. Yoon, K.-J., L.L. Wu, J.J. Zimmerman, et al. 1996. Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs. Viral Immunol 9:51-63.
141. Yoon, K.-J., L.L. Wu, J.J. Zimmerman, et al. 1997. Field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) vary in their susceptibility to antibody dependent enhancement (ADE) of infection. Vet Microbiol 55:277-287.
142. Yoon, K.-J., J.J. Zimmerman, S.L. Swenson, et al. 1995. Characterization of the humoral immune response to porcine reproductive and respiratory syndrome (PRRS) virus infection. J Vet Diagn Invest 7:305-312.
143. Zoellner, B., H.H. Feucht, and R. Laufs. 1992. Role of proteases as cofactors for antibody-dependent enhancement of HIV. AIDS 6:887-888.